Paricalcitol prevents MAPK pathway activation and inflammation in adriamycin-induced kidney injury in rats
Paricalcitol plays a renoprotective role by modulating renal inflammation and cell proliferation. These results highlight potential targets for treating CKD.
Authors
- Terezila Machado Coimbra (ORCID: https://orcid.org/0000-0002-2906-8231)
- Beatriz Magalhães Oliveira (ORCID: https://orcid.org/0000-0002-7021-5707)
- Cleonice Giovanini
- Amanda Lima Deluque (ORCID: https://orcid.org/0000-0002-8827-7172)
- Cláudia Silva Souza (ORCID: https://orcid.org/0000-0002-3210-1434)
- Lucas Ferreira de Almeida (ORCID: https://orcid.org/0000-0002-5731-1219)
- Ana Lívia Dias Maciel
- Roberto Silva Costa
- Heloı́sa Della Coletta Francescato (ORCID: https://orcid.org/0000-0001-6034-1235)
Institutions
- Universidade de São Paulo (BR)
- Clinics Hospital of Ribeirão Preto (BR)
- Institute of Biomedical Science (GB)
- University of Virginia (US)
Publication Details
- Journal
- Journal of Pathology and Translational Medicine
- Published
- 2024-08-26
- DOI
- https://doi.org/10.4132/jptm.2024.07.12
- Citations
- 2
- Primary Topic
- Erythrocyte Function and Pathophysiology
- Type
- article
- Field-Weighted Citation Impact
- 0.65
Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico